Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Lofexidine 是一种选择性α2 受体激动剂,常用于缓解海洛因和其他阿片类戒断的躯体症状。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
5 mg | ¥ 228 | 现货 | ||
10 mg | ¥ 326 | 现货 | ||
25 mg | ¥ 587 | 现货 | ||
50 mg | ¥ 840 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 326 | 现货 |
产品描述 | Lofexidine is a selective α2-receptor agonist, Lofexidine reduces narcotic withdrawal symptoms. |
体内活性 | Lofexidine significantly decreased SOWS scores compared to placebo and demonstrated better retention rates in participants undergoing opioid withdrawal. Lofexidine potentially offers a useful non-opioid alternative to treat opioid withdrawal symptoms[1]. |
动物实验 | 8-day, randomized, double-blind, placebo-controlled, parallel-group study in 264 patients dependent on short-acting opioids evaluated the efficacy of lofexidine hydrochloride in reducing withdrawal symptoms in patients undergoing opioid withdrawal.?The primary efficacy measures were SOWS-Gossop on Day 3 and time-to-dropout.?Secondary endpoints included the proportion of participants who were completers;?area under the 5-day SOWS-Gossop - time curve (i.e., AUC1-5), and daily mean SOWS-Gossop, OOWS-Handelsman, MCGI (subject and rater), and VAS-E scores.?Participants received lofexidine HCl 3.2mg daily in four divided doses or matching placebo on Days 1-5, followed by 2days of placebo[1]. |
分子量 | 259.13 |
分子式 | C11H12Cl2N2O |
CAS No. | 31036-80-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 62.5 mg/mL (241.19 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 3.8591 mL | 19.2953 mL | 38.5907 mL | 96.4767 mL |
5 mM | 0.7718 mL | 3.8591 mL | 7.7181 mL | 19.2953 mL | |
10 mM | 0.3859 mL | 1.9295 mL | 3.8591 mL | 9.6477 mL | |
20 mM | 0.193 mL | 0.9648 mL | 1.9295 mL | 4.8238 mL | |
50 mM | 0.0772 mL | 0.3859 mL | 0.7718 mL | 1.9295 mL | |
100 mM | 0.0386 mL | 0.193 mL | 0.3859 mL | 0.9648 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Lofexidine 31036-80-3 GPCR/G Protein Neuroscience Adrenergic Receptor inhibit Inhibitor Beta Receptor inhibitor